BD Alaris platform, the BD AlarisTM 2 TM
TM
neXus PK Syringe Pump
Timely, precise and effective anaesthesia Managing your patients’ anaesthesia requires precise devices1
effective anaesthesia for children and adults. Improving workflow efficiency
Workflow efficiency is highly important in busy operating rooms (OR)
. BD Alaris neXus PK offers a user-friendly interface and a large display showing all critical infusion data at a glance.
Promoting patient safety During complex OR procedures, patient safety is a concern. The BD Alaris
TM
Increased medication safety for all population The BD Alaris
TM neXus PK syringe pump has neXus PK offers a broad range of plasma (PK) and
effect site (PD) targeting models. The Eleveld Propofol and Eleveld Remifentanil models are the only TCI models able to provide PD target steering for children. They help anaesthetists meet IV anaesthesia requirements in a safe, timely and accurate way
3 .
Wi-Fi enabled Wireless transfer of infusion data through the Alaris
TM
Communication Engine to the hospital information systems. Automatic wireless download of pump event logs and the update of datasets from anywhere in the hospital improves the process without interrupting clinical workflows as pumps are infusing.
patent pending medication safety to minimise the potential for programming errors, especially when setting up infusions for children. This technology automatically adjusts the suggested default settings for height and weight based on the patient’s age that is entered when using the Eleveld propofol and Eleveld remifentanil TCI model. .
New TCI drug models* • Dexmedetomidine (Hannivoort-Colin) • Propofol (Eleveld), • Remifentanil (Eleveld), • Remifentanil (Kim-Obara-Egan) * refer to specifications for full list of drug models.
. Built on the BD AlarisTM neXus neXus PK syringe pump is designed to offer timely, precise and
References 1 The_Safety_of_Target_Controlled_Infusions. Schnider (v0.1) TW, Minto CF, Struys MM, Absalom AR. The Safety of Target- Controlled Infusions. Anesth Analg. 2016 Jan;122(1):79-85. doi: 10.1213/ANE.0000000000001005. PMID: 26516801. 2 The Joint Commission International Standards. 7th Edition: January 2021. 3 Vandemoortele O, Hannivoort LN, Vanhoorebeeck F, Struys MMRF, Vereecke HEM. General Purpose Pharmacokinetic-Pharmacodynamic Models for Target-Controlled Infusion of Anaesthetic Drugs: A Narrative Review. J Clin Med. 2022 Apr 28;11(9):2487. doi: 10.3390/jcm11092487. PMID: 35566617; PMCID: PMC9101974.
1030 Eskdale Road, Winnersh Triangle, Wokingham, RG41 5TS
bd.com/anaesthesia-uk BD, the BD Logo and Alaris are trademarks of Becton, Dickinson and Company. © 2022 BD. All rights reserved. (BD-91562, August 2023)
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76
